A descriptive exploratory study of how admissions caused by medication-related harm are documented within inpatients’ medical records

BMC Health Services Research

Bryony Dean Franklin¹  Ann Jacklin²  Mary Hickson¹  Matthew Reynolds³ 

[1]Imperial College Healthcare NHS Trust, Charing Cross Hospital, Fulham Palace Road, London W6 8RF, UK

[2]Centre for Medication Safety and Service Quality, Imperial College Healthcare NHS Trust and UCL School of Pharmacy, Pharmacy Department, Ground Floor, Charing Cross Hospital, Fulham Palace Road, London W6 8RF, UK

[3]Imperial College London, London SW7 2AZ, UK

关键词: Adherence;    Medication errors;    Adverse drug reactions;    Medical record;    UK;    Hospital admissions;   

Others  :  1130770
DOI  :  10.1186/1472-6963-14-257

 received in 2013-12-31, accepted in 2014-06-10,  发布年份 2014

【 摘 要 】

Background

Adverse drug reactions, poor patient adherence and errors, here collectively referred to as medication-related harm (MRH), cause around 2.7-8.0% of UK hospital admissions. Communication gaps between successive healthcare providers exist, but little is known about how MRH is recorded in inpatients’ medical records. We describe the presence and quality of MRH documentation for patients admitted to a London teaching hospital due to MRH. Additionally, the international classification of disease 10th revision (ICD-10) codes attributed to confirmed MRH-related admissions were studied to explore appropriateness of their use to identify these patients.

Methods

Clinical pharmacists working on an admissions ward in a UK hospital identified patients admitted due to suspected MRH. Six different data sources in each patient’s medical record, including the discharge summary, were subsequently examined for MRH-related information. Each data source was examined for statements describing the MRH: symptom and diagnosis, identification of the causative agent, and a statement of the action taken or considered. Statements were categorised as ‘explicit’ if unambiguous or ‘implicit’ if open to interpretation. ICD-10 codes attributed to confirmed MRH cases were recorded.

Results

Eighty-four patients were identified over 141 data collection days; 75 met our inclusion criteria. MRH documentation was generally present (855 of 1307 statements were identified; 65%), and usually explicit (705 of 855; 82%). The causative agent had the lowest proportion of explicit statements (139 of 201 statements were explicit; 69%). For two (3%) discharged patients, the causal agent was documented in their paper medical record but not on the discharge summary. Of 64 patients with a confirmed MRH diagnosis at discharge, only six (9%) had a MRH-related ICD-10 code.

Conclusions

Availability of information in the paper medical record needs improving and communication of MRH-related information could be enhanced by using explicit statements and documenting reasons for changing medications. ICD-10 codes underestimate the true occurrence of MRH.

【 授权许可】

   
2014 Reynolds et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]Royal Pharmaceutical Society, BMJ: British National Formulary. 62nd edition. London: BMJ Group and Pharmaceutical Press; 2011.
• [2]Vincent C, Barber N, Franklin BD, Burnett S: The Contribution of Pharmacy to making Britain a Safer Place to Take Medicines. London: Royal Pharmaceutical Society; 2009.
• [3]Barber N, Alldred DP, Raynor DK, Dickinson R, Garfield S, Jesson B, Lim R, Savage I, Standage C, Buckle P, Carpenter J, Franklin BD, Woloshynowych M, Zermansky AG: Care homes’ use of medicines study: prevalence, causes and potential harm of medication errors in care homes for older people. Qual Saf Health Care 2009, 18(5):341-346.
• [4]Howard R, Avery AJ, Partridge M, Howard PD: Investigation into the reasons for preventable drug related admissions to a medical admissions unit: observational study. Qual Saf Health Care 2003, 12(4):280-285.
• [5]Cunningham G, Dodd TR, Grant DJ, McMurdo ME, Richards RM: Drug-related problems in elderly patients admitted to Tayside hospitals, methods for prevention and subsequent reassessment. Age Ageing 1997, 26(5):375-382.
• [6]Bhalla N, Duggan C, Dhillon S: Drug-related admissions to hospital. Pharm J 2003, 270:583-586.
• [7]Pirmohamed M, James S, Meakin S, Green CF, Scott AK, Walley TJ, Farrar K, Park BK, Breckenridge AM: Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ 2004, 329:15-19.
• [8]Hopf Y, Watson M, Williams D: Adverse-drug-reaction related admissions to a hospital in Scotland. Pharm World Sci 2008, 30(6):854-862.
• [9]Muehlberger N, Schneeweiss S, Hasford J: Adverse drug reaction monitoring—cost and benefit considerations. Part I: frequency of adverse drug reactions causing hospital admissions. Pharmacoepidemiol Drug Saf 1997, 6(Suppl 3):S71-S77.
• [10]Winterstein AG, Sauer BC, Hepler CD, Poole C: Preventable Drug-Related Hospital Admissions. Ann Pharmacother 2002, 36:1238-1248.
• [11]Royal Pharmaceutical Society: Keeping patients safe when they transfer between care providers – getting the medicines right. London: Royal Pharmaceutical Society; 2011.
• [12]Witherington EMA, Pirzada OM, Avery AJ: Communication gaps and readmissions to hospital for patients aged 75 years and older: observational study. Qual Saf Health Care 2008, 17(1):71-75.
• [13]Gandara E, Moniz T, Ungar J, Lee J, Chan-Macrae M, O’Malley T, Schnippner JL: Communication and information deficits in patients discharged to rehabilitation facilities: an evaluation of five acute care hospitals. J Hosp Med 2009, 4(8):E28-E33.
• [14]Franklin BD, Reynolds M, Shebl NA, Burnett S, Jacklin A: Prescribing errors in hospital inpatients: a three-centre study of their prevalence, types and causes. Postgrad Med J 2011, 87(1033):739-745.
• [15]Health Informatics Unit. A Clinician’s Guide to Record Standards - Part 2: Standards for the structure and content of medical records and communications when patients are admitted to hospita. London: Digital and Health Information Policy Directorate; 2008.
• [16]Van der Linden CMJ, Kerskes MCH, Bijl AMH, Maas HAAM, Egberts ACG, Jansen PAF: Represcription After Adverse Drug Reaction in the Elderly: A Descriptive Study. Arch Intern Med 2006, 166:1666-1667.
• [17]Van Der Linden CMJ, Jansen PAF, Van Marum RJ, Grouls RJE, Korsten EHM, Egberts ACG: Recurrence of adverse drug reactions following inappropriate re-prescription: better documentation, availability of information and monitoring are needed. Drug Saf 2010, 33(7):535-538.
• [18]McLeod M, Ahmed Z, Barber N, Franklin BD: A national survey of inpatient medication systems in English NHS hospitals. BMC Health Serv Res 2014, 14:93.
• [19]Hallas J, Harvald B, Gram LF, Grodum E, Brøsen K, Haghfelt T, Damsbo N: Drug related hospital admissions: the role of definitions and intensity of data collection, and the possibility of prevention. J Intern Med 1990, 228:83-90.
• [20]Sim J, Wright CC: The kappa statistic in reliability studies: use, interpretation, and sample size requirements. Phys Ther 2005, 85(3):257-268.
• [21]Dornan T, Ashcroft D, Lewis P, Miles J, Taylor D, Tully M, Wass V: An in depth investigation into causes of prescribing errors by foundation trainees in relation to their medical education. London: EQUIP study; 2010.
• [22]Tully M, Cantrill J: Insights into creation and use of prescribing documentation in the hospital medical record. J Eval Clin Pract 2005, 11(5):430-437.
• [23]Fernando B, Kalra D, Morrison Z, Byrne E, Sheikh A: Benefits and risks of structuring and/or coding the presenting patient history in the electronic health record: systematic review. BMJ Qual Saf 2012, 21(4):337-346.
• [24]Leendertse A, Egberts A, Stoker L, van den Bemt P: Frequency and Risk Factors for Preventable Medication-Related Hospital Admissions in the Netherlands. Arch Int Med 2008, 168(17):1890-189625.
• [25]Howard R, Avery AJ, Slavenburg S, Royal S, Pipe G, Lucassen P, Pirmohamed M: Which drugs cause preventable admissions to hospital? A systematic review. Br J Clin Pharmacol 2006, 63(2):136-147.
• [26]Wu T-Y, Bottle MJA, Molokhia M, Aylin P, Bell D, Majeed A: Ten-year trends in hospital admissions for adverse drug reactions in England 1999–2009. J R Soc Med 2010, 103(6):239-250.
• [27]Zhang M, Holman CDJ, Preen DB, Brameld K: Repeat adverse drug reactions causing hospitalization in older Australians: a population-based longitudinal study 1980–2003. Br J Clin Pharmacol 2007, 63(2):163-170.
• [28]Honigman B, Lee J, Rothschild J, Light P, Pulling RM, Yu T, Bates DW: Using computerized data to identify adverse drug events in outpatients. J Am Med Inform Assoc 2001, 8(3):254-266.
• [29]Brvar M, Fokter N, Bunc M, Mozina M: The frequency of adverse drug reaction related admissions according to method of detection, admission urgency and medical department specialty. BMC Clin Pharmacol 2009, 9:8.